Hemodynamic and Coagulation Responses to 1-Desamino[8-D-Arginine] Vasopressin in Patients with Congenital Nephrogenic Diabetes Insipidus

New England Journal of Medicine

Volumn 318, Issue 14, 1988, Pages 881-887

  Bichet, Daniel G ^a   Razi, Mohammad ^a   Lonergan, Michèle ^a   Arthus, Marie Françoise ^a   Papukna, Vassiliki ^a   Kortas, Claude ^a   Barjon, Jean Noël ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODYNAMICS; HEREDITY; HUMAN; NEPHROGENIC DIABETES INSIPIDUS; PRIORITY JOURNAL;

EID: 0023856917     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198804073181403     Document Type: Article

References (36)

1. Culpepper RM, Hebert SC, Andreoli TE. Nephrogenic diabetes insipidus. In: Standbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease. 5th ed. New York: McGraw-Hill, 1983:1867–88.
2. Williams RH, Henry C. Nephrogenic diabetes insipidus: transmitted by females and appearing during infancy in males. Ann Intern Med 1947; 27: 84–95.
3. Moses AM, Scheinman SS, Schroeder ET. Studies on the effects of vasopressin on increasing vascular resistance and urinary prostaglandin E2 excretion, and on inhibiting plasma renin activity in patients with hereditary nephrogenic diabetes insipidus. Clin Res 1982; 30: 703A. abstract.
4. Orr FR, Filipich RL. Studies with angiotensin in nephrogenic diabetes insipidus. Can Med Assoc J 1967; 97: 841–5.
5. Moses AM, Scheinman SJ, Schroeder ET. Antidiuretic and PGE2 response to AVP and dDAVP in subjects with central and nephrogenic diabetes insipidus. Am J Physiol 1985; 248: F354–F359.
6. Jard S. Vasopressin receptors. In: Czernichow P, Robinson AG, eds. Frontiers of hormone research. Vol. 13. Diabetes insipidus in man. Basel: S. Karger, 1985:89–104.
7. Pliška V. Pharmacology of deamino-d-arginine vasopressin. In: Czernichow P, Robinson AG, eds. Frontiers of hormone research. Vol. 13. Diabetes insipidus in man. Basel: S. Karger, 1985:278–91.
8. Mannucci PM, Åberg M, Nilsson IM, Robertson B. Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol 1975; 30: 81–93.
9. Mannucci PM, Canciani MT, Rota L, Donovan BS. Response of factor VIII/von Willebrand factor to dDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease. Br J Haematol 1981; 47: 283–93.
10. Richardson DW, Robinson AG. Desmopressin. Ann Intern Med 1985; 103: 228–39.
11. Williams TDM, Lightman SL, Leadbeater MJ. Hormonal and cardiovascular responses to dDAVP in man. Clin Endocrinol (Oxf) 1986; 24: 89–96.
12. Schwartz J, Liard J-F, Ott C, Cowley AW Jr. Hemodynamic effects of neurohypophyseal peptides with antidiuretic activity in dogs. Am J Physiol 1985; 249: H1001–H1008.
13. Derkx FH, Man in't Veld AJ, Jones R, Reid JL, Schalekamp MA. DDAVP (1-desamino-8-D-arginine vasopressin): An antagonist of the pressor action of endogenous vasopressin? J Hypertens 1983; 1: Suppl 2: 58–61.
14. Grant PJ, Davies JA, Prentice CRM. Vasopressins and factor VIII release. Lancet 1985; 2: 224.
15. Kobrinsky NL, Doyle JJ, Israels ED, et al. Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus. Lancet 1985; 1: 1293–4.
16. McKusick VA. Mendelian inheritance in man: diabetes insipidus renal type I. 7th ed. Baltimore: Johns Hopkins University Press, 1986:1345.
17. Bichet DG, Kortas C, Manzini C, Barjon JN. A specific antibody to vasopressin in a man with concomitant resistance to treatment with Pitressin. Clin Chem 1986; 32: 211–2.
18. Pedersen EB, Lamm LV, Albertson K, et al. Familial cranial diabetes insipidus: a report of five families: genetic, diagnostic and therapeutic aspects. Q J Med 1985; 57: 883–96.
19. Simone JV, Vanderheiden J, Abildgaard CF. The semiautomatic one-stage factor VIII assay with a commercially prepared standard. J Lab Clin Med 1967; 69: 706–12.
20. Cejka J. Enzyme immunoassay for Factor VIII–related antigen. Clin Chem 1982; 28: 1356–8.
21. Bichet DG, Kortas C, Mettauer B, et al. Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure. Kidney Int 1986; 29: 1188–96.
22. Bichet DG, Arthus MF, Barjon JN, Lonergan M, Kortas C. Human platelet fraction arginine-vasopressin: potential physiologic role. J Clin Invest 1987; 79: 881–7.
23. Winer BJ. Statistical principles in experimental design. 2nd ed. New York: McGraw-Hill, 1971.
24. Dunnett CW. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 1955; 50: 1096–121.
25. Cort JH, Fischman AJ, Dodds WJ, Rand JH, Schwarz FL. New category of vasopressin receptor in the central nervous system: evidence that this receptor mediates the release of a humoral Factor VIII-mobilizing principle. Int J Pept Protein Res 1981; 17: 14–22.
26. Budiansky S. Research fraud: false data confessed. Nature 1983; 301: 101.
27. Liard JF. Acute hemodynamic effects of antidiuretic agonists. In: Cowley AW, Liard JF, Ausiello DA, eds. Vasopressin: cellular and integrative functions. New York: Raven Press (in press).
28. Walker BR. Evidence for a vasodilatory effect of vasopressin in the conscious rat. Am J Physiol 1986; 251: H34–H39.
29. Belch JJF, Small M, McKenzie F, et al. DDAVP stimulates prostacyclin production. Thromb Haemost 1982; 47: 122–3.
30. Liard JF. Characterization of acute hemodynamic effects of antidiuretic agonists in conscious dogs. J Cardiovasc Pharmacol (in press).
31. Mannucci PM, Ruggeri ZM, Pareti FI, Capitanio A. 1-Deamino-8-D-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand's disease. Lancet 1977; 1: 869–72.
32. Kobrinsky NL, Watson CM, Cheang MS, Bishop AJ. Improved hemophilia A carrier detection by DDAVP stimulation of factor VIII. J Pediatr 1984; 104: 718–24.
33. Prowse CV, Sas G, Gader AMA, Cort JH, Cash JD. Specificity in the factor VIII response to vasopressin infusion in man. Br J Haematol 1979; 41: 437–47.
34. Vincente V, Corrales J, Miralles J, Alberca I. Normal responses to DDAVP in patients with pathology of the hypothalamoneurohypophyseal axis. Thromb Res 1987; 45: 695–7.
35. Graham JB, Elston RC, Barrow ES, Reisner HM, Namboodiri KK. Statistical methods for carrier detection in the hemophilias. In: Bloom AL, ed. The hemophilias. New York: Churchill Livingstone, 1982:156–75.
36. Zerbe RL, Robertson GL. A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. N Engl J Med 1981; 305: 1539–46.